South Wales, March 16 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "ADENOVO" on Feb. 25. The details about the trademark application no. UK00004345442 published in the journal no. 2026/011 (March 13).

With Dehns as representative, Theolytics Ltd filed the trademark application for the below mentioned good(s)/service(s).

Class 1 : Chemicals used in science; biological preparations for use in science; biochemicals for research use; biochemicals based on viruses for scientific or research use.

Class 5 : Medical and veterinary preparations; biological preparations for the treatment of cancer and cancer indications; reagents, diagnostics and therapeutic preparations for use in the treatment of various cancers and cancer indications; viruses for therapeutic purposes; oncolytic viral therapies; biological therapies; pharmaceutical preparations for use in oncology.

Class 35 : Compilation of computer databases; compilation of computer databases for use in the fields of medicine, pharmacology, clinical research and therapeutics; compilation, collection and systematisation of information into computer databases; compilation, collection and systematisation of information into computer databases for use in the fields of medicine, pharmacology, clinical research and therapeutics; computer database management; computer database management in the fields of medicine, pharmacology, clinical research and therapeutics; updating and maintenance of data in computer databases; updating and maintenance of data in computer databases for use in the fields of medicine, pharmacology, clinical research and therapeutics; statistical analysis and reporting services; statistical analysis and reporting services in the fields of medicine, pharmacology, clinical research and therapeutics; compilation of statistical data; compilation of statistical data in the fields of medicine, pharmacology, clinical research and therapeutics; data collection, processing, retrieval and management; data collection, processing, retrieval and management in the fields of medicine, pharmacology, clinical research and therapeutics; information, advice and consultancy relating to the aforesaid.

Class 42 : Scientific and technological services and research and design relating thereto; medical and pharmacological research services; research and development services in the field of oncology; oncology research; medical research; development of therapies for treating cancer and cancer indications; research into the use of viruses in the treatment of diseases; consultancy relating to the research and development in the field of therapeutics; research and testing services in the field of virology; DNA screening for scientific and medical research purposes; phenotypic screening for scientific and medical research purposes; drug discovery services; pharmaceutical drug development services; design and development of computer software and computer database programs; design and development of computer software and computer database programs for use in the fields of medicine, pharmacology, clinical research and therapeutics; providing medical, pharmacological, therapeutic, and clinical research information and data; software as a service; software as a service for use in the fields of medicine, pharmacology, clinical research and therapeutics; platform as a service; platform as a service for use in the fields of medicine, pharmacology, clinical research and therapeutics; database development services; database development services for use in the fields of medicine, pharmacology, clinical research and therapeutics; information, advice and consultancy relating to the aforesaid.

Class 44 : Medical and pharmaceutical information services; providing information relating to clinical trials; providing information in the fields of medicine, pharmacology, clinical research and therapeutics; genetic testing for medical purposes; advice and consultancy relating to the aforesaid.

The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004345442

Disclaimer: Curated by HT Syndication.